Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
125.96
-2.68 (-2.08%)
At close: Apr 28, 2026, 4:00 PM EDT
135.01
+9.05 (7.18%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Palvella Therapeutics Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Palvella Therapeutics stock have an average target of 171.87, with a low estimate of 38 and a high estimate of 270. The average target predicts an increase of 36.45% from the current stock price of 125.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Palvella Therapeutics stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 12 | 12 | 12 | 11 | 11 |
| Buy | 4 | 4 | 5 | 5 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 16 | 17 | 17 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $210 → $240 | Strong Buy | Maintains | $210 → $240 | +90.54% | Mar 31, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $255 → $270 | Strong Buy | Maintains | $255 → $270 | +114.35% | Mar 24, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $210 | Strong Buy | Maintains | $210 | +66.72% | Mar 16, 2026 |
| Mizuho | Mizuho | Buy Maintains $205 → $250 | Buy | Maintains | $205 → $250 | +98.48% | Feb 25, 2026 |
| BTIG | BTIG | Strong Buy Maintains $192 → $215 | Strong Buy | Maintains | $192 → $215 | +70.69% | Feb 25, 2026 |
Financial Forecast
Revenue This Year
27.20K
Revenue Next Year
28.41M
from 27.20K
Increased by 104,350.18%
EPS This Year
-5.11
from -3.71
EPS Next Year
-6.47
from -5.11
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 420,000 | 77.4M | ||||||
| Avg | 27,203 | 28.4M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 284,368.1% | ||||||
| Avg | - | 104,350.2% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.32 | -2.87 | ||||||
| Avg | -5.11 | -6.47 | ||||||
| Low | -6.37 | -12.32 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.